Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...
Childhood-onset striatonigral neurodegeneration robs children of the ability to walk and talk by age five. Researchers at ...
Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Currently, there are only two cell and gene therapies (CGTs) within the gastroenterology market. (Image Credits: Pixabay) The global cell and gene therapy (CGT) market is poised for exceptional ...
Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
2d
Emirates News Agency on MSNDoH introduces advanced gene-editing therapy for sickle cell disease, thalassemia for first time in UAEThe innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with ...
Healthcare Asia Magazine on MSN3d
Global cell and gene therapy market to reach $76b in 2030It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results